Cell cultures in replacement therapy

Cell replacement therapy is one of the top priority areas of modern medicine, which is aimed at restoring the structure and functions of damaged tissues by transplanting cells grown in vitro . The article summarizes data obtained in several studies of diploid cell lines (allogeneic fibroblasts) used as replacement therapy in various therapeutic areas as part of application of medical technology innovations. The article describes benefits of using fibroblasts and the routes of cell culture administration. At present the use of medicinal products containing viable human cells (biomedical cell products) is regulated by Federal Law 180-FZ «On biomedical cell products» of 23 June 2016. Cell cultures used in the production of biomedical cell products should be morphologically homogeneous populations of cells derived from a specific tissue and should have a limited life span, a stable karyotype (at least 75 % of cells should have a double set of chromosomes), should not be associated with cancer risks, be free from extraneous agents, have low levels of histocompatibility antigens expression. According to 180-FZ, all characteristics of a cell line supporting the quality of a biomedical cell product should be reflected in the biomedical cell product specification. Before the adoption of 180-FZ only certified cell cultures could be clinically used. The therapeutic potential of fibroblasts related to optimization of reparative processes, improvement of regenerative and adaptive capabilities, as well as the accumulated experience of their clinical use are stirring interest to the development of fibroblast-based biomedical cell products and their use as replacement therapy. However, it should be pointed out that according to 180-FZ biomedical cell products may not be produced using «biological material obtained by interrupting or jeopardising an embryo/fetus development process».

клеточные культуры, диплоидные клетки, аутофибробласты, аллофибробласты, трансплантация клеток, трансплантация тканей, биомедицинские клеточные продукты, cell cultures, diploid cells, autologous fibroblasts, allogeneic fibroblasts, cell transplantation, tissue transplantation, biomedical cell products

1. Medawar PB. Sheets of pure epidermal epithelium from human skin. Nature 1941; (148): 783–4.

2. Medawar PB. The cultivation of adult mammalian sêin epithelium in vitro. Quart Microsc Sci. 1948; 89: 187–96.

3. Maksimov AA. In vitro culture of adult mammals conjunctive tissue. Russkij arhiv anatomii, gistologii i embriologii 1916; 1(1): 115–82 (in Russian).

4. Rumjantcev AV. The Great Soviet Encyclopedia 1975; 22: 391–392 (in Russian).

5. Timofeevskij AD. Long-term tissue cultures and malignancy of cells. Vestnik Akademii medicinskih nauk SSSR 1964; 11(3): 205–6 (in Russian).

6. Khlopin NG. The Great Soviet Encyclopedia 1986; 26: 556 (in Russian).

7. Hrushhov GK. The Great Soviet Encyclopedia 1978; 28: 407 (in Russian).

8. Sanford KK, Earle WR, Likely GD. The growth in vitro of single isolated tissue cells. J Natl Cancer Inst. 1948; 9(3): 229–46.

9. Sanford KK, Merwin RM, Hobbs GL, Young JM. Clonal analósis of variant cell lines transformed to malignant cells in tissue culture. J Natl Cancer Inst. 1959; 23: 1035–59.

10. Eagle H. Nutrition needs of mammalian cells in tissue culture. Sñience 1955; 122(3168): 501–14.

11. Kolokol’tsova TD, Yurchenko ND, Nechaeva EA, Radaeva IF, Shalunova NV, Petruchuk EM, et al. Obtaining of certified human fibroblasts that are suitable for scientific and medical studies. Biotechnology in Russia 2007; (1): 58–64 (in Russian).

12. Bobro LI. Fibroblasts and their significance in tissue reactions. Arkhiv Patologii 1990; 52(12): 65–8 (in Russian).

13. Goncharova VP. Fibroblast growth factors (a short review). Fiziologicheskii Zhurnal Imeni I. M. Sechenova 1994; 9(80): 163–73 (in Russian).

14. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961; 25: 585–621.

15. Coulomb B, Saiag P, Bell E, Breitburd F, Lebreton C, Heslan M, Dubertret L. A new method for studying epidermalization in vitro. Br J Dermatol. 1986; 114(1): 91–101.

16. Coulomb B, Lebreton C, Dubertret L. Influence of human dermal fibroblasts on epidermalization. J Invest Dermatol. 1989; 92(1): 122–5.

17. Tumanov VP, Zhakota DA, Korchagina NS. 30year experience of development and application of cell technologies in clinical practice. Plasticheskaja hirurgija i kosmetologija 2012; (3): 433–49 (in Russian).

18. Olefir YuV, Medunitsyn NV, Avdeeva ZhI, Soldatov AA, Movsesyants AA, Merkulov VA, Bondarev VP. Modern biological/biotechnological medicinal products. Topical issues and prospects for development. BIOpreparations. Prevention, Diagnosis, Treatment 2016; 16(2): 67–77 (in Russian).

19. Chaplygin SS. Application of allofibroblasts in the treatment of wound defects in the skin (experimental study). Cand. Med. Sci. [dissertation]. Samara; 2013 (in Russian).

20. Keller G, Sebastian J, Lacombe U, Toft K, Lask G, Revazova E. Safety of injectable autologous human fibroblasts. Bulletin of Experimental Biology and Medicine 2000; 130(8): 786–9 (in Russian).

21. Gerlach JC, Johnen C, Ottomann C, Bräutigam K, Plettig J, Belfekroun C, et al. Method for autologous single skin cell isolation for regenerative cell spraó transplantation with non-cultured cells. Int J Artif Organs 2011; 34(3): 271–9.

22. Savinceva IV, Selezneva II, Gavrilyk BK. Collagen type 1 based and chitosan hydrogen is a system of immobilization and directional cell delivery. In: Stem Cells and Perspectives of Their Use in Health Care: Proc. Conference. Moscow, 2006. P. 19–20 (in Russian).

23. Hrupina AS, Yurkevich YuV, Smolyaninov AB, Trofimova IL, Supilnikova OV, Krylov KV, et al. The use of hydroxyethyl cellulose gel as a carrier for transplantation of cultured allogenic fibroblasts on extensive wound surfaces. Zdorov’e — osnova chelovecheskogo potenciala: problemy i puti ih reshenija 2013; 8(2): 698–700 (in Russian).

24. Adamjan AA, Golovanova PM, Dobysh SV, Kilimchuk LE, Kriger AG, Fronchek EV. Biological composition for the treatment of wounds «Kollahit». Patent RF, ¹ 2108114; 1998 (in Russian).

25. Sarkisov DS, Fedorov VD, Glushchenko EV, Alekseev AA, Tumanov VP, Serov GG et al. Use of cultured fibroblasts for restoration of skin in severe burns. Bulletin of Experimental Biology and Medicine 1995; (6): 566–70 (in Russian).

26. Alekseev AA, Sarkisov DS, Jashin AJu, Kashin JuD, Krutikov MG. Skin regeneration of by using cultured allofibroblasts. In: New medical technologies in the treatment of heavy-burned: Proc. Scientific and practical conference. Moscow, 1997. P. 52 (in Russian).

27. Alekseev AA, Kashin YuD, Jashin AYu, Rahaev AM. The technique of surgical treatment based on the application of cultured allofibroblasts. In: New methods of treating burns using cultured skin cells: Proc. IIth Int. Symp. Saratov, 1998. P. 9–12 (in Russian).

28. Alejnik DJa, Aminev VA, Charykova IN, Kuvakina NA. The use of modern biotechnologies for the treatment of superficial burns in young children. In: New methods of treating burns using cultured skin cells: Proc. IIth Int. Symp. Saratov, 1998. P. 6–8 (in Russian)

29. Rashitova AD, Fayazov RR, Muhamedyanov GS, Chistostupov KS. Stem cell technology in the complex treatment of trophic ulcers in severe chronic venous insufficiency. Kubanskij nauchnyj medicinskij vestnik 2008; (6): 60–3 (in Russian).

30. Sedov VM, Andreev DYu, Smirnova TD, Paramonov BA, Enkina TN, Sominina AA, et al. Cell therapy in treatment of trophic ulcers of lower extremities. Vestn Khir Im I I Grek. 2006; 165(2): 90–4 (in Russian).

31. Vinnik YuS, Salmina AB, Drobushevskaya AI, Teplyakova OV, Pogilenkova EA, Zicova LD. The cell technologies and the tissue engineering are for healing chronic wounds. Vestnik Eksperimental’noj i Klinicheskoj Hirurgii 2011; 4(2): 392–7 (in Russian).

32. Pomatilov AA. Treatment of acute and chronic wounds in otorhinolaryngology by the method of transplantation of cultured human allofibroblasts. Dr. Med. Sci. [dissertation]. Moscow; 2008 (in Russian).

33. Tumanov VP, Pal’chun VT, Pomatilov AA, Mironov AA. Method for eliminating a traumatic defect of the tympanic membrane. Patent RF, ¹ 2165765; 2001 (in Russian).

34. Gundorova RA, Makarov PV, Vasilyev AV, Terskih VV, Hodzhabekyan GV, Pravilnikova PA, et al. Method for treating corneal erosion. Patent RF, ¹ 2173122; 2001 (in Russian).

35. Runova GS. The use of cultured allofibroblasts in the complex treatment of periodontal diseases. Dr. Med. Sci. [dissertation]. Moscow; 2000 (in Russian).

36. Kjarimova RR, Lahonina KA, Farkashdi Sh. The use of fibroblasts in dentistry. Elektronnyj nauchno-obrazovatel’nyj vestnik «Zdorov’e i obrazovanie v XXI veke» 2008; 10(12): 486–7 (in Russian).

37. Tumanov VP, Runova GS, Tumanova EL. Method of regeneration of the jaw bone structures. Patent RF, ¹ 2336830; 2008 (in Russian).

38. Kriheli EA, Zgurskij AA, Terehov SM. Application of autologous fibroblasts in cosmetology. Esteticheskaja medicina 2004; 3(4): 336–42 (in Russian).

39. Zorin VL, Zorina AI, Cherkasov VR, Kopnin PB, Deev RV, Isaev AA, et al. Face skin condition quality and quantity estimation after autologous dermal fiberblasts application. Vestnik Esteticheskoj mediciny 2011; 10(2): 16–26 (in Russian).

40. Zorina AI, Zorin VL, Cherkasov VR. Dermal fibroblasts: a variety of phenotypes and physiological functions, a role in skin aging. Esteticheskaja medicina 2012; 11(1): 15–31 (in Russian).

41. Andzhaparidze OG, Dosser EM, Rapoport RI, Unanov SS, Dorofeev VM, Iablokova ML et al. Live measles vaccine from human diploid cells (safety, reactogenicity and immunogenicity. Vopr Virusol. 1967; (6): 651–7 (in Russian).

42. HAVRIX® Instruction for medical use. VIDAL Medicines Compendium. Available from: https://www.vidal.ru/drugs/havrix_924 (in Russian).

43. FS. 3.3.1.0024.15. Rubella vaccine live cultural attenuated. State Pharmacopoeia of the Russian Federation. 13th ed. V. 3. P. 964–72. Available from: http://www.femb.ru/feml (in Russian).

44. Kolokol’tsova TD, Shalunova NV, Petruchuk EM. To the question of controlling the safety of cell cultures suitable for substitution therapy. BIOpreparations. Prevention, Diagnosis, Treatment 2006; (2): 8–12 (in Russian).

45. Radaeva IF, Nechaeva EA, Drozdov IG. Collection of cell cultures FGUN GNC VB «Vector» Rospotrebnadzor. Novosibirsk: TCERIS; 2009. P. 251 (in Russian).

46. Shalunova NV, Merculov VA, Comratov AV, Petruchuk EM, Semenova IS, Volgin AR, Trusov GA. Requirements for cell cultures, used for manufacture and quality control of immunobiological medicines. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2013; (1): 28–32 (in Russian).

47. Melnikova EV, Merkulova OV, Rachinskaya OA, Chaplenko AA, Merkulov VA, Olefir YuV, et al. Modern approaches to quality control of cell-therapy products. Biopharmaceutical J. 2016; 8(4): 35–46 (in Russian).

48. Hvatov VB, Konyushko OI, Ermolov AS, Smirnov SV, Zhirkova EA, Bocharova VS, Mironova LL. Treatment of burn wound. Patent RF, ¹ 2373944, 2009 (in Russian).

49. Grudjanov AI, Erohin AI, Bjakova SF. Application of preparations of firm «Geistlich» (Bio-Oss, Bio-Gide). Novoe v stomatologii 2001; (8): 72–7 (in Russian).

50. Glinskikh NP, Ustyancev IV, Baharev AA, Ustyancev PV, Bahareva TL. Method of obtaining drugs for medical purposes. Patent RF, ¹ 2398873, 2010 (in Russian).

51. Shtukaturov AK, Markovskaja OV, Salistyj PV. Organization of assistance to children with thermal trauma in the Sverdlovsk region In: Proc. IIIth congress of Russia combustiologists. Moscow, 2010. P. 49–51 (in Russian).

52. Glinskikh NP, Novikova IA, Ron’ GI, Ustyancev IV. Cell cultures based composition for the treatment of inflammatory periodontal diseases. Patent RF, ¹ 2210352; 2003 (in Russian).

53. Glinskikh NP, Donnik IM, Poryvayeva AP, Shilova EN, Ustyantsev IV. The use of lyophilized preparation allofibroblasts for treatment of diseases caused by the herpes virus. Agrarnyj vestnik Urala 2012; 7(99): 25–7 (in Russian).

54. OFS. 1.7.2.0011.15. Requirements for cell cultures — substrates for the production of immunobiological drugs. State Pharmacopoeia of the Russian Federation. 13th ed. V. 2. P. 672–88. Available from: http://www.femb.ru/feml (in Russian).

55. Kolokol’tsova TD, Nechaeva EA, Jurchenko ND. Strain of human diploid cells for replacement therapy (variants). Patent RF, ¹ 2285040; 2006 (in Russian).

56. The Federal Law of June 23, 2016 ¹ 180-FZ «On Biomedical Cell Products» (in Russian).